MICAL1 inhibits colorectal cancer cell migration and proliferation by regulating the EGR1/β-catenin signaling pathway.

[1]  G. Tonon,et al.  WNT Signaling in Hematological Malignancies , 2020, Frontiers in Oncology.

[2]  Zhiyi Wei,et al.  F-actin disassembly factor MICAL1 binding to Myosin Va mediates cargo unloading during cytokinesis , 2020, Science Advances.

[3]  D. Pei,et al.  Friend or foe, the role of EGR-1 in cancer , 2019, Medical Oncology.

[4]  K. Akashi,et al.  Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells , 2018, Proceedings of the National Academy of Sciences.

[5]  Z. Dong,et al.  MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance , 2018, Theranostics.

[6]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[7]  Jun Du,et al.  MICAL1 facilitates breast cancer cell proliferation via ROS‐sensitive ERK/cyclin D pathway , 2018, Journal of cellular and molecular medicine.

[8]  Y. Chen,et al.  MICAL2 promotes breast cancer cell migration by maintaining epidermal growth factor receptor (EGFR) stability and EGFR/P38 signalling activation , 2018, Acta physiologica.

[9]  M. Vanoni.  Structure-function studies of MICAL, the unusual multidomain flavoenzyme involved in actin cytoskeleton dynamics. , 2017, Archives of biochemistry and biophysics.

[10]  V. Gladyshev,et al.  Regulated methionine oxidation by monooxygenases. , 2017, Free radical biology & medicine.

[11]  J. Shay,et al.  Amplification of F-Actin Disassembly and Cellular Repulsion by Growth Factor Signaling. , 2017, Developmental cell.

[12]  A. Houdusse,et al.  Emerging roles of MICAL family proteins – from actin oxidation to membrane trafficking during cytokinesis , 2017, Journal of Cell Science.

[13]  A. Houdusse,et al.  Oxidation of F-actin controls the terminal steps of cytokinesis , 2017, Nature Communications.

[14]  M. Boutros,et al.  Wnt signaling in cancer , 2016, Oncogene.

[15]  Jun Du,et al.  MICAL1 controls cell invasive phenotype via regulating oxidative stress in breast cancer cells , 2016, BMC Cancer.

[16]  F. Roviello,et al.  MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion , 2015, Oncotarget.

[17]  C. Karapetis,et al.  Colorectal cancer: Metastases to a single organ. , 2015, World journal of gastroenterology.

[18]  Genevieve Housman,et al.  EMT and tumor metastasis , 2015, Clinical and Translational Medicine.

[19]  M. Brizzi,et al.  Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells , 2014, Oncotarget.

[20]  Ewout J. N. Groen,et al.  The intracellular redox protein MICAL-1 regulates the development of hippocampal mossy fibre connections , 2014, Nature Communications.

[21]  Jane Y. Wu,et al.  USP33, a new player in lung cancer, mediates Slit-Robo signaling , 2014, Protein & Cell.

[22]  A. Rosenwald,et al.  PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. , 2013, Blood.

[23]  Y. Yoo,et al.  Sanguinarine induces apoptosis in human colorectal cancer HCT-116 cells through ROS-mediated Egr-1 activation and mitochondrial dysfunction. , 2013, Toxicology letters.

[24]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[25]  M. Toyota,et al.  Association between genomic alterations and metastatic behavior of colorectal cancer identified by array‐based comparative genomic hybridization , 2013, Genes, chromosomes & cancer.

[26]  Seung Cheol Kim,et al.  Down-regulated expression of ATG5 in colorectal cancer. , 2012, Anticancer research.

[27]  J. Rohn,et al.  Differential regulation of actin microfilaments by human MICAL proteins , 2012, Journal of Cell Science.

[28]  T. Beißbarth,et al.  Mutated KRAS results in overexpression of DUSP4, a MAP‐kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas , 2010, Genes, chromosomes & cancer.

[29]  Krzysztof Goryca,et al.  Modeling Oncogenic Signaling in Colon Tumors by Multidirectional Analyses of Microarray Data Directed for Maximization of Analytical Reliability , 2010, PloS one.

[30]  Ruei-Jiun Hung,et al.  Mical links semaphorins to F-actin disassembly , 2010, Nature.

[31]  M. Kurokawa,et al.  Blimp-1 is a tumor suppressor gene in lymphoid malignancies , 2010, International journal of hematology.

[32]  Boon Chuan Low,et al.  A genetic pathway composed of Sox14 and Mical governs severing of dendrites during pruning , 2009, Nature Neuroscience.

[33]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[34]  M. Saegusa,et al.  Transcription factor Egr1 acts as an upstream regulator of β‐catenin signalling through up‐regulation of TCF4 and p300 expression during trans‐differentiation of endometrial carcinoma cells , 2008, The Journal of pathology.

[35]  R. deLeeuw,et al.  Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies , 2009, Leukemia.

[36]  M. Janssen-Heijnen,et al.  Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[37]  S. Strittmatter,et al.  Release of MICAL Autoinhibition by Semaphorin-Plexin Signaling Promotes Interaction with Collapsin Response Mediator Protein , 2008, The Journal of Neuroscience.

[38]  Charles Auffray,et al.  Deciphering cellular states of innate tumor drug responses , 2006, Genome Biology.

[39]  Stefano Monti,et al.  Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma , 2006, The Journal of experimental medicine.

[40]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Rowan,et al.  Characterization of the E‐cadherin/catenin complex in colorectal carcinoma cell lines , 2004, International journal of experimental pathology.

[42]  H. Müller-Hermelink,et al.  Chromosome 6 suffers frequent and multiple aberrations in thymoma. , 2002, The American journal of pathology.

[43]  Tianyi Mao,et al.  MICALs, a Family of Conserved Flavoprotein Oxidoreductases, Function in Plexin-Mediated Axonal Repulsion , 2002, Cell.

[44]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[45]  T. Barrette,et al.  ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.